January 18, 2024

Springer Nature Research Communities→

January 18, 2024/ Guest User

Unveiling the Journey Behind a Breakthrough in Early Detection of Pancreatic Cancer

New paper demonstrates effectiveness of exosome isolation technology in detecting Stage I and II pancreatic ductal adenocarcinoma (PDAC)

Biological Dynamics - Exosome Tell The Story

Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.

The ExoVerita™ Pro instrument and ExoVita™ Pancreas test described is for Research Use Only. Not for diagnostic purposes.
Biological Dynamics’s Clinical Laboratory is CLIA-certified and CAP accredited.

Media

Biological Dynamics - Exosome Tell The Story